Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

More men are getting cosmetic procedures, mainly for aging, hair loss, and to keep masculine features, with growing interest in both surgical and noninvasive treatments.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

Extracts improve hair growth in alopecia.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Lower SHBG levels may increase the risk of PCOS.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Melatonin helps Cashmere goats grow more hair by affecting certain genes and cell pathways.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.